Tom Reilly has been removed as the CEO of Melbourne Racing Club. Reilly was called to Caulfield Racecourse at 7.15pm to be told by chairman John Kanga his position was “untenable”.

Originally published as ‘Best to pivot and move on’: John Kanga announces removal of Tom Reilly as CEO of Melbourne Racing Club. Join the conversation. Add your comment to this story.

Melbourne Racing Club chairman John Kanga has revealed the sudden removal of chief executive Tom Reilly. Reilly, the former Thoroughbred Breeders Australia and Aushorse chief executive, joined the ...

Exchanging hands for $366, the stock is up 33% in 12 months and 16% in 2025. In the first quarter, it reported a revenue of $9.5 billion, up 10% year-over-year, and an EPS of $2.58, up 8% year ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

The Melbourne Racing Club announced on Monday that Tom Reilly has been removed as CEO. “Sometimes it just doesn't work out,” MRC chairman John Kanga said in a press statement.

Eli Lilly and Company (LLY)’s share was trading at $765.68 as of 5 th June. LLY’s trailing and forward P/E were 62.30 and 35.09 respectively according to Yahoo Finance.

Melbourne Racing Club chairman John Kanga has revealed the sudden removal of chief executive Tom Reilly. Gilbert Gardiner Melbourne Racing Club chairman John Kanga (left) and former CEO Tom Reilly.

Former New England Patriots coach Bill Belichick was linked to the Tampa Bay Buccaneers head coaching job.

Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right now, Lilly sells tirzepatide, commercialized as Mounjaro for type 2 ...

Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, permitting longer dosing intervals. Lilly plans to apply the technology ...